Compare Kian Santang Muliatama Tbk. (RGAS) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kian Santang Muliatama Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Kian Santang Muliatama Tbk. trades at Rp114 (market cap 163.43B, 36.43M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,730 (market cap 12.36T, 1.41M 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 75.6× Kian Santang Muliatama Tbk.'s market cap, and Kian Santang Muliatama Tbk. is more actively traded (36.43M versus 1.41M). Which is the better fit depends on your goals.
| RGAS | TSPC | |
|---|---|---|
Market Cap | 163.43B | 12.36T |
Volume | 36.43M | 1.41M |
Lot | 364.26K | 14.08K |
Turnover | 4B | 3.83B |
Average Price | 109.89 | 2,722.04 |
Value | 4B | 3.83B |
Indicative Equilibrium Price | 114 | 2,730 |
Indicative Equilibrium Volume | 5.9K | 2.51K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kian Santang Muliatama Tbk.
PT Kian Santang Muliatama Tbk (the Entity) was established based on the Notarial Deed of Artisa Khamelia Ramadiyanti, S.H., M.Kn., No. 634, dated November 28, 2018. The Entity started its commercial operations on 2019. The controlling party for the Company is Edy Nurhamid Amin.
Read more on RGAS →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
